Warning: The NCBI web site requires JavaScript to function. more...
Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption.
Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR, Cawston TE, Clark IM.
Arthritis Res Ther. 2005;7(3):R503-12. Epub 2005 Feb 22.
Related citations
Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes.
Wang X, Song Y, Jacobi JL, Tuan RS.
Growth Factors. 2009 Feb;27(1):40-9.
Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
Flannery CR, Little CB, Caterson B, Hughes CE.
Matrix Biol. 1999 Jun;18(3):225-37.
Effects of glucocorticoids and interleukin-1 beta on expression and activity of aggrecanases in equine chondrocytes.
Busschers E, Holt JP, Richardson DW.
Am J Vet Res. 2010 Feb;71(2):176-85.
Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM, Rowan AD, Cawston TE, Young DA.
Arthritis Res Ther. 2006;8(5):R142.
Histone deacetylases--a new target for suppression of cartilage degradation?
Mort JS.
Arthritis Res Ther. 2005;7(4):155-6. Epub 2005 Jun 16.
Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular.
Legendre F, Bogdanowicz P, Boumediene K, Pujol JP.
J Rheumatol. 2005 Jul;32(7):1307-16.
Regulation of type II collagen expression by histone deacetylase in articular chondrocytes.
Huh YH, Ryu JH, Chun JS.
J Biol Chem. 2007 Jun 8;282(23):17123-31. Epub 2007 Apr 10.
Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes.
Wada Y, Shimada K, Sugimoto K, Kimura T, Ushiyama S.
Int Immunopharmacol. 2006 Feb;6(2):144-55. Epub 2005 Aug 24.
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
Pattoli MA, MacMaster JF, Gregor KR, Burke JR.
J Pharmacol Exp Ther. 2005 Oct;315(1):382-8. Epub 2005 Jul 11.
Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system.
Arai M, Anderson D, Kurdi Y, Annis-Freeman B, Shields K, Collins-Racie LA, Corcoran C, DiBlasio-Smith E, Pittman DD, Dorner AJ, Morris E, LaVallie ER.
Osteoarthritis Cartilage. 2004 Aug;12(8):599-613.
Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes.
Fichter M, Körner U, Schömburg J, Jennings L, Cole AA, Mollenhauer J.
J Orthop Res. 2006 Jan;24(1):63-70.
Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways.
Legendre F, Bogdanowicz P, Martin G, Domagala F, Leclercq S, Pujol JP, Ficheux H.
Clin Exp Rheumatol. 2007 Jul-Aug;25(4):546-55.
Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes.
Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier JP, Duval N, Fahmi H.
Osteoarthritis Cartilage. 2008 Oct;16(10):1267-74. Epub 2008 Apr 15.
Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.
Elliott S, Rowan AD, Carrère S, Koshy P, Catterall JB, Cawston TE.
Ann Rheum Dis. 2001 Feb;60(2):158-65.
Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.
Liacini A, Sylvester J, Li WQ, Zafarullah M.
Arthritis Res Ther. 2005;7(4):R777-83. Epub 2005 Apr 4.
Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, Clark IM.
Arthritis Res Ther. 2006;8(4):R124.
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.
Koshy PJ, Lundy CJ, Rowan AD, Porter S, Edwards DR, Hogan A, Clark IM, Cawston TE.
Arthritis Rheum. 2002 Apr;46(4):961-7.
Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation.
Karsdal MA, Sumer EU, Wulf H, Madsen SH, Christiansen C, Fosang AJ, Sondergaard BC.
Arthritis Rheum. 2007 May;56(5):1549-58.
Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes.
Liacini A, Sylvester J, Zafarullah M.
Biochem Biophys Res Commun. 2005 Feb 4;327(1):320-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on